Evidence map›Paper›PMID 26069204›Full record

ArticleCancer prevention research (Philadelphia, Pa.)2015

St. John's Wort Attenuates Colorectal Carcinogenesis in Mice through Suppression of Inflammatory Signaling.

Soumen K Manna, Srujana Golla, Jaya Prakash Golla, Naoki Tanaka, Yan Cai, Shogo Takahashi, Kristopher W Krausz, Tsutomu Matsubara, Ilia Korboukh, Frank J Gonzalez

Open access · greenAbstract read
In one paragraph

Article in Cancer prevention research (Philadelphia, Pa.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact, top 90% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Pharmaceuticals (Basel, Switzerland) · 2023
    Review
  3. Article
  4. Article
  5. St. John's Wort alleviates dextran sodium sulfate-induced colitis through pregnane X receptor-dependent NFκB antagonism.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
    Article
  6. Anti-Tumor Activity ofAntioxidants (Basel, Switzerland) · 2020
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Soumen K MannaLaboratory of Metabolism, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
Srujana GollaLaboratory of Metabolism, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
Jaya Prakash GollaLaboratory of Metabolism, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
Naoki TanakaLaboratory of Metabolism, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
Yan CaiLaboratory of Metabolism, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
Shogo TakahashiLaboratory of Metabolism, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
Kristopher W KrauszLaboratory of Metabolism, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
Tsutomu MatsubaraLaboratory of Metabolism, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
Ilia KorboukhSyncon, Inc., Atwood, California.
Frank J GonzalezLaboratory of Metabolism, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland. gonzalef@mail.nih.gov.
National Cancer Institute · USAnsys (United States) · US

Funding

Xenobiotic receptorsZIABC005562 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI GONZALEZ, FRANK J · 2009 to 2025
$26.9M
Xenobiotic ReceptorsZIABC005708 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI GONZALEZ, FRANK J · 2009 to 2025
$16.4M
Xenobiotic-Metabolizing EnzymesZ01BC005562 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI GONZALEZ, FRANK J · 1996 to 2008
$1.3M
Intramural NIH HHS Z01 BC005562
6 · The paper itself

Abstract

Despite widespread use as well as epidemiologic indications, there have been no investigations into the effect of St. John's wort (SJW) extract on colorectal carcinogenesis in vivo. This study reports a systematic evaluation of the impact of dietary supplementation of SJW extract on azoxymethane-induced colorectal carcinogenesis in mice. Mice were fed with either AIN-93G (control) diet or SJW extract-supplemented diet (SJW diet) prior to azoxymethane treatment. SJW diet was found to significantly improve the overall survival of azoxymethane-treated mice. Pretreatment with the SJW diet significantly reduced body weight loss as well as decrease of serum albumin and cholesterol levels associated with azoxymethane-induced colorectal tumorigenesis. SJW diet-fed mice showed a significant decrease in tumor multiplicity along with a decrease in incidence of large tumors and a trend toward decreased total tumor volume in a dose-dependent manner. A short-term study, which examined the effect of SJW prior to rectal bleeding, also showed decrease in colorectal polyps in SJW diet-fed mice. Nuclear factor kappa B (NF-κB) and extracellular signal-regulated kinase (ERK1/2) pathways were attenuated by SJW administration. SJW extract resulted in early and continuous attenuation of these pathways in the colon epithelium of SJW diet-fed mice under both short-term and long-term treatment regimens. In conclusion, this study demonstrated the chemopreventive potential of SJW extract against colorectal cancer through attenuation of proinflammatory processes.

Indexed as

AnimalsAnticarcinogenic AgentsAzoxymethaneCarcinogenesisCell Transformation, NeoplasticColonColorectal NeoplasmsDietDietary SupplementsDisease Models, AnimalExtracellular Signal-Regulated MAP KinasesHypericumInflammationMaleMiceNF-kappa BAnticarcinogenic AgentsAzoxymethaneExtracellular Signal-Regulated MAP KinasesNF-kappa BOligonucleotidesPlant Extracts

Identifiers

PMID26069204
PMCPMC4584416
OpenAlexW2306987396

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.